May 9, 2012 — Sound Interventions Inc. announced the successful completion of the company's first-in-human renal ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
May 09, 2012
May 4, 2012 - Medtronic Inc. announced six-month pooled outcomes from randomized and crossover patients in the ...
May 04, 2012
May 2, 2012 — Vessix Vascular Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology ...
May 02, 2012
April 11, 2012 — ReCor Medical disclosed updated data for the REDUCE First-In-Man clinical study of its CE-marked ...
April 12, 2012April 4, 2012 — Medtronic Inc. announced that the Symplicity renal denervation system provides safe, significant and ...
April 05, 2012March 29, 2012 — Internet-based telemedicine systems appear to lead to more appropriate and effective pharmacotherapy ...
March 29, 2012February 29, 2012 — Vessix Vascular Inc. announced initial patient treatments in the international multicenter Reduce ...
February 29, 2012
February 20, 2012 — ReCor Medical announced that its Paradise percutaneous ultrasound renal denervation system for ...
February 20, 2012
February 15, 2012 — Vessix Vascular Inc., developer of a novel percutaneous radiofrequency (RF) balloon catheter ...
February 15, 2012
February 15, 2012 — Medtronic Inc. announced the start of two clinical initiatives evaluating the broader, real-world ...
February 15, 2012
October 26, 2011 — Medtronic Inc. announced the start of SYMPLICITY HTN-3, the company’s United States clinical trial of ...
October 26, 2011
August 10, 2011 – The U.S. Food and Drug Administration (FDA) has approved Abbott’s RX Herculink Elite Renal Stent ...
August 10, 2011
August 2, 2011 – The U.S. Food and Drug Administration said it recently cleared Abbott Vascular’s RX Herculink Elite ...
August 02, 2011
July 14, 2011 — The U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3 ...
July 14, 2011June 14, 2011 – New performance measures for adults with coronary artery disease (CAD) and hypertension were released ...
June 14, 2011© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now